Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus
Sign Up to like & getrecommendations! Published in 2024 at "Sultan Qaboos University Medical Journal"
DOI: 10.18295/squmj.1.2024.006
Abstract: Objectives This study aimed to evaluate the safety and efficacy of remogliflozin compared to vildagliptin as an add-on drug to metformin in type 2 diabetes mellitus (T2DM) treatment. Metformin is considered a first-line drug in… read more here.
Keywords: vildagliptin; diabetes mellitus; remogliflozin; type diabetes ... See more keywords
918-P: Effect of Remogliflozin in Improving NYHA Class Compared with Empagliflozin in Type 2 Diabetes Patients with Heart Failure (Remit HF)
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes"
DOI: 10.2337/db24-918-p
Abstract: Background: In patient of T2DM and HF, reduced ejection fraction (HFrEF) constitutes the majority of HF cases, posing significant risk of mortality. NYHA classification, recommended in global HF guidelines, independently predicts mortality. SGLT2i have shown… read more here.
Keywords: improvement; remogliflozin; class iii; class ... See more keywords